Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT2080224807Phase 1Completed
Phase 1, randomised, double-blind trial comparing Adrenomedullin arm with Placebo arm (2 arms). Primary endpoint: Primary safety and tolerability endpoints. Started Jul 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT2080224807.